Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer

CME test	Downloadable PDF	PowerPoint slides	CME Information and Faculty Disclosures
Read Dr Love's original email (from August 3, 2010)			Subscribe to Dr Love's email alerts

Slides from presentations at ASCO 2010 and transcribed comments from recent interviews with Richard M Goldberg, MD (6/23/10) and Axel Grothey, MD (7/9/10)

 

Bokemeyer C et al. Cetuximab with chemotherapy (CT) as first-line treatment for metastatic colorectal cancer (mCRC): Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation status. Proc ASCO 2010;Abstract 3506.

Alberts SR et al. Adjuvant mFOLFOX6 with or without cetuximab in K-RAS wild type patients with resected stage III colon cancer: Results from NCCTG Intergroup phase III trial N0147. Proc ASCO 2010;Abstract CRA3507.

Goldberg RM et al. Adjuvant mFOLFOX6 plus or minus cetuximab in patients with K-RAS mutant resected stage III colon cancer: NCCTG Intergroup phase III trial N0147. Proc ASCO 2010;Abstract 3508.

Go to previous Journal Club